Erwei Yatie Keli (二维亚铁颗粒)二维亚铁颗粒
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 福寿堂制药有限公司Chinese legal name: 福寿堂制药有限公司
主要成分Active Ingredients
- 蔗糖Zhe Tang
- 每包克Meibao Ke
- 维生素C毫克Weisheng Suhao Ke
- 辅料为柠檬酸Recorded Chinese composition: 辅料为柠檬酸
药物知识说明
蔗糖是一种在国家药监局注册认定的药品。该药品含有每包克、维生素c毫克、蔗糖-ff4eac60等成分。
该药品关联的活性成分包括：每包克、维生素c毫克、蔗糖Zhe Tang。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：福寿堂制药有限公司Chinese legal name: 福寿堂制药有限公司。
您可以探索含有相同成分的其他药品：每包克-d242b309成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 二维亚铁颗粒) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 蔗糖Zhe Tang.
Manufacturers recorded for this product: 福寿堂制药有限公司Chinese legal name: 福寿堂制药有限公司.
Explore other medicines containing the same ingredient: 每包克 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 二维亚铁颗粒Recorded Chinese name: 二维亚铁颗粒
- 剂型Dosage form: 颗粒剂Granules
- 规格Specification: 复方Recorded Chinese specification
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 福寿堂制药有限公司Chinese legal name: 福寿堂制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H43021754
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H43021754
Manufacturer
Chinese legal name: 福寿堂制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H43021754
生产企业
福寿堂制药有限公司(国产)
适应症
用于各种原因引起的缺铁性贫血。
用法用量
口服。成人一次1包（5克），一日3次。饭后服用。
不良反应
1.可见恶心、呕吐、胃部或腹部不适或疼痛。
2.可减少肠蠕动，引起便秘并排黑便。
禁忌
1.含铁血黄素沉着症及不伴有缺铁的其他贫血患者禁用。
2.血色病患者禁用。
3.严重肝肾功能不全者禁用。
注意事项
1.不得长期使用，应在医师确诊为缺铁性贫血后使用，且治疗期间应定期检查血象和血清铁水平。
2.肝肾功能不全、消化性溃疡、胰腺炎、肠道炎症等患者慎用。
3.儿童用量请咨询医师或药师。
4.不能与浓茶同服。
5.对本品过敏者禁用，过敏体质者慎用。
6.本品性状发生改变时禁止使用。
7.请将本品放在儿童不能接触的地方。
8.儿童必须在成人监护下使用。
9.如正在使用其他药品，使用本品前请咨询医师或药师。
贮藏
遮光，密封，在阴凉处干燥处保存。
规格
复方
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.